Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Status:
Recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether AGuIX (Activation and Guidance of
Irradiation by X-ray) gadolinium-based nanoparticles make radiation work more effectively in
the treatment of patients with brain metastases that are more difficult to control with
stereotactic radiation alone.